Legal Representation
Attorney
Lisa C. Pavento
USPTO Deadlines
Next Deadline
1942 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-11-26)
Due Date
November 26, 2030
Grace Period Ends
May 26, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
23 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Nov 26, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
Nov 26, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Sep 24, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Sep 24, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Sep 4, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Aug 22, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Aug 21, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
Aug 21, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Aug 21, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Aug 21, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Aug 20, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Aug 20, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Aug 20, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Jul 19, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jul 19, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jul 18, 2024 | ALIE | A | ASSIGNED TO LIE | Loading... |
Jan 31, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Nov 7, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Nov 7, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Nov 7, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Oct 30, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Oct 14, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Oct 9, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Reagents for medical use for measurement of HBs antibody; medicines consisting of RNA for treating cancer; crude medicines for treating ocular diseases; cellular function activating agents for medical purposes; colostral antibodies for veterinary purposes; chemico-pharmaceutical preparations for treating cancer; chemical preparations for use in DNA analysis for medical purposes; chemical preparations for use in RNA analysis for medical purposes; bacterial preparations for medical and veterinary use; chemical preparations for treating cancer for medical or veterinary purposes; biotechnological preparations for medical purposes, namely, reagents for medical purposes; biological reagents for medical purposes; Biochemical preparations for the medical treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorder; reagents for medical use; bispecific colostral antibody for medical use; trace element preparations being dietary supplements for human use; clinical medical reagents; pharmaceutical preparations for the treatment of cancer; medical diagnostic reagents for the detection of mRNA antigens; colostral antibodies for medical purposes
Class 009
DNA analysis apparatus, namely, medical laboratory research instruments for DNA analysis; DNA chips; RNA microarrays; cartridges for storing specimen used for RNA analysis apparatus, namely, solid phase extraction cartridges for laboratory use; reagent cartridges used for RNA analysis apparatus, namely, solid phase extraction cartridges for laboratory use; reagent containers used for RNA analysis apparatus, namely, solid phase extraction cartridges for laboratory use; RNA analysis apparatus, namely, medical laboratory research instruments for RNA analysis; RNA sequencing devices, namely, laboratory devices for detecting genetic sequences; RNA chips; genome analyzer machines, namely, laboratory devices for detecting genetic sequences and related downloadable computer operating software; devices for analyzing genome information, namely, laboratory devices for detecting genetic sequences; bioreactors for cell culturing for scientific research; biochip analyzing apparatus for research or scientific purposes; biochip sensors for sensing antigens; biochips for research or scientific purposes; liquid dosage devices that measure the amounts to be dispensed, namely, dispensers for measuring and dispensing of distilled water, not for medical use; incubators for cell culture, not for medical purposes; cellchip inspectors being optical inspection apparatus; devices for analyzing protein sequence used as laboratory apparatus, namely, laboratory devices for detecting genetic sequences; physical and chemical machines for laboratory use; physical and chemical apparatus for analyzing genes, namely, laboratory devices for detecting genetic sequences; gene amplifiers being DNA microarrays; mRNA microarrays; RNA, DNA, and mRNA microarrays; nucleic acid sequencing devices and nucleic acid synthetic apparatus, namely, laboratory devices for detecting genetic sequences; diagnostic chips for inspecting blood plasma laboratory apparatus, namely, DNA chips; diagnostic chips for analyzing blood plasma laboratory apparatus, namely, DNA chips
Class 042
RNA technology research and development; providing temporary use of non-downloadable web application for sharing information in the RNA technology field; research in the field of RNA repair technology; research and development of RNA chips; research relating to science, namely, scientific research in the field of RNA; RNA screening for scientific research purposes; RNA sequence analysis for scientific research purposes; multiple nucleic acid analysis for scientific research purposes; molecular analysis for scientific research purposes; development of new technology for others in the field of biotechnology; biochemical analysis; drug discovery services; design of new products for others; pharmaceutical research and development; clinical studies of medicines, namely, conducting clinical trials for others; services for assessing the efficiency of pharmaceuticals, namely, product quality testing services; fusion protein analysis for scientific research purposes; computer programming services in the medical field; medical laboratories; management assistance services for medical image data, namely, engineering services; medicine research being medical research; analysis and evaluation of medical product development, namely, product quality testing services; providing scientific information on the testing, inspection and research of medical products; scientific and medical laboratory services relating to the production of bispecific antibody antibodies; pharmaceutical drug development for bispecific antibody; bispecific antibody research and development; evaluating of clinical trial progress, namely, conducting clinical trials for others; clinical trials, namely, conducting clinical trials for others; providing temporary use of online, non-downloadable computer operating software for genome analyzer machines
Classification
International Classes
005
009
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"RNA DESIGN"